Literature DB >> 22747475

Significance of C4d deposition in antibody-mediated rejection.

Asami Takeda1, Yasuhiro Otsuka, Keiji Horike, Daijo Inaguma, Takahisa Hiramitsu, Takayuki Yamamoto, Koji Nanmoku, Norihiko Goto, Yoshihiko Watarai, Kazuharu Uchida, Kunio Morozumi, Takaaki Kobayashi.   

Abstract

The C4d staining as a special tissue marker for humoral immunity has served criteria of pathological diagnosis for antibody-mediated rejection (ABMR) in Banff classification since 2003. However, the sensitivity and specificity of C4d staining have been questioned, and recently, C4d-negative ABMR has been more focused in renal allograft pathology. The aim of this study was to make certain of C4d staining for ABMR that was diagnosed by clinical and morphological findings. C4d staining was employed by immunofluorescence. This study included 14 patients with acute ABMR and 16 with chronic active ABMR. Eight of acute ABMR were ABO-blood-type-incompatible renal transplantation (ABOinRTx) pre-treated by DFPP and splenectomy or rituximub. In acute ABMR after ABOinRTx, C4d staining along peritubular capillary (PTC) was positive in five of them (62.5%). Only one graft biopsy of five acute ABMR with donor-specific antibody (DSA) showed C4d positive. We assembled 16 graft biopsies showing typical transplant glomerulopathy and thickened PTC basement membrane with peritubular capillaritis as a suspicious pathological chronic active ABMR. Four of eight DSA-positive patients were C4d negative in PTC; however, three of four DSA-positive and C4d-negative patients in PTC chronic active ABMR were C4d positive in only glomerular capillaries. C4d positivity could not come to a specific marker of ABMR diagnosing based on clinically and ordinary morphological findings.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747475     DOI: 10.1111/j.1399-0012.2012.01642.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

1.  Late coexistent acute cellular and antibody-mediated rejection in non-sensitized renal transplant patients.

Authors:  P J Phelan; D N Howell; S R Smith; M J Ellis
Journal:  Int Urol Nephrol       Date:  2013-08-08       Impact factor: 2.370

2.  Placental C4d as a common feature of chromosomally normal and abnormal miscarriages.

Authors:  Joong Yeup Lee; Joon-Seok Hong; Eun Na Kim; Soyeon Ahn; Jin Choe; Doyeong Hwang; Ki Chul Kim; Seok Hyun Kim; Chong Jai Kim
Journal:  Virchows Arch       Date:  2014-03-27       Impact factor: 4.064

3.  Educational Case: Renal allograft rejection.

Authors:  Harrison Dai; Shirui Chen; Jolanta Kowalewska
Journal:  Acad Pathol       Date:  2022-06-21

4.  Evaluation of Renal Allograft Biopsies for Graft Dysfunction and Relevance of C4d Staining in Antibody Mediated Rejection.

Authors:  Clement Wilfred Devadass; Aruna Vishwanth Vanikar; Lovelesh Kumar Nigam; Kamal Vinod Kanodia; Rashmi Dalsukhbhai Patel; Kyasakkala Sannaboraiah Vinay; Himanshu V Patel
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Renal cortical necrosis in a renal transplant recipient.

Authors:  M Eswarappa; V Ravi; V Mysorekar
Journal:  Indian J Nephrol       Date:  2013-05

Review 6.  Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.

Authors:  Anat R Tambur; Patricia Campbell; Anita S Chong; Sandy Feng; Mandy L Ford; Howard Gebel; Ronald G Gill; Garnett Kelsoe; Vasilis Kosmoliaptsis; Roslyn B Mannon; Michael Mengel; Elaine F Reed; Nicole M Valenzuela; Chris Wiebe; I Esme Dijke; Harold C Sullivan; Peter Nickerson
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

Review 7.  The importance of C4d in biopsies of kidney transplant recipients.

Authors:  Rosana Rosa Miranda Corrêa; Juliana Reis Machado; Marcos Vinícius da Silva; Fernanda Rodrigues Helmo; Camila Souza Oliveira Guimarães; Laura Penna Rocha; Ana Carolina Guimarães Faleiros; Marlene Antônia dos Reis
Journal:  Clin Dev Immunol       Date:  2013-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.